Dr. Wiernik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1000 10th Ave
11th Fl
New York, NY 10019Phone+1 212-636-3338Fax+1 212-523-2004- Is this information wrong?
Education & Training
Johns Hopkins UniversityResidency, Internal Medicine, 1970 - 1971
The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 1969 - 1970- The MetroHealth System/Case Western Reserve UniversityInternship, Internal Medicine, 1965 - 1966
University of Virginia School of MedicineClass of 1965
National Institutes of Health Clinical CenterFellowship, Medical Oncology
Certifications & Licensure
NY State Medical License 1982 - 2025
FL State Medical License 2016 - 2018
VA State Medical License 1965 - 2018
MD State Medical License 1971 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Kwit Memorial Award American College of Clinical Pharmacology, 2019
- Fellow (FASCO) American Society of Clinical Oncologists, 2008
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia Start of enrollment: 2006 Jun 01
- Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Start of enrollment: 2006 Sep 15
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting Start of enrollment: 2010 Dec 02
Publications & Presentations
PubMed
- Families with non-Hodgkin lymphoma and plasma cell dyscrasias in their pedigrees.Peter H Wiernik, Janice P Dutcher> ;Journal of Investigative Medicine. 2024 Jan 1
- Higher than normal mitochondrial DNA content associated with better outcome in acute promyelocytic leukaemia? Maybe.Peter H Wiernik> ;British Journal of Haematology. 2023 Jan 1
- 12 citationsCNS involvement in AML at diagnosis is rare and does not affect response or survival: data from 11 ECOG-ACRIN trials.Chezi Ganzel, Ju-Whei Lee, Hugo F. Fernandez, Elisabeth Paietta, Selina M. Luger, Hillard M. Lazarus, Larry D. Cripe, Dan Douer, Peter H. Wiernik, Jacob M. Rowe, Marti...> ;Blood Advances. 2021 Nov 23
- Join now to see all
Grant Support
- Minority Based Community Clinical Oncology ProgramNational Cancer Institute2001–2006
- Eastern Cooperative Oncology GroupNational Cancer Institute1985–1992
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
